North America Pneumonia Testing Market (2018 - 2024)
The North America Pneumonia Testing Market would witness market growth of 8.3% CAGR during the forecast period (2018 – 2024). Pneumonia is a complicated infection affecting lower respiratory tract with symptoms such as short breathing, fever, chest pain, nausea, and vomiting. In the case of pneumonia, the air sacs of lungs called as alveoli, get filled with fluid or pus, causing inflammation. The condition is mainly caused due to microorganisms such as bacteria, virus, fungi, and parasites and affecting people with weak immune system. The case is quite common in children and older people. Based on WHO studies, pneumonia is one of the major causes of death among children and is estimated to affect approximately 1.2 million children under the age of five years, on an annual basis. As per WHO, 95% of all pneumococcal episodes occur in children in the developing countries. The demand for pain management drugs in the recent years is on the rise. POC testing is a revolutionary technology, which is now an ideal technique that is used in detecting pneumonia. The POC test can be carried out from the comfort of one’s home to bedside diagnosis in hospitals. Growing popularity for POC tests within the healthcare sector would add the market attractiveness during the forecast period.
Based on Method, the market is segmented into Point-Of-Care (POC) Testing, Immunodiagnostics and Molecular Diagnostics. Based on End User, the market is segmented into Diagnostic Centers, Hospitals, Homecare and Others. Based on type, the market is segmented into Analyzers and Consumables. Based on Technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC) and Other Technology.. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
Based on Method, the market is segmented into Point-Of-Care (POC) Testing, Immunodiagnostics and Molecular Diagnostics. Based on End User, the market is segmented into Diagnostic Centers, Hospitals, Homecare and Others. Based on type, the market is segmented into Analyzers and Consumables. Based on Technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC) and Other Technology.. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pneumonia Testing Market, by Method
1.4.2 North America Pneumonia Testing Market, by End User
1.4.3 North America Pneumonia Testing Market, by Type
1.4.4 North America Pneumonia Testing Market, by Technology
1.4.5 North America Pneumonia Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD
3.1.1 North America Point-Of-Care (POC) Testing Pneumonia Testing Market by Country
3.1.2 North America Immunodiagnostics Pneumonia Testing Market by Country
3.1.3 North America Molecular Diagnostics Pneumonia Testing Market by Country
CHAPTER 4. NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER
4.1.1 North America Pneumonia Testing Diagnostic Centers Market by Country
4.1.2 North America Pneumonia Testing Hospitals Market by Country
4.1.3 North America Pneumonia Testing Homecare Market by Country
4.1.4 North America Other End User Pneumonia Testing Market by Country
CHAPTER 5. NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE
5.1.1 North America Analyzers Pneumonia Testing Market by Country
5.1.2 North America Consumables Pneumonia Testing Market by Country
CHAPTER 6. NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY
6.1.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Pneumonia Testing Market by Country
6.1.2 North America Immunofluorescence Pneumonia Testing Market by Country
6.1.3 North America Western Blot Pneumonia Testing Market by Country
6.1.4 North America Polymerase Chain Reaction (PCR) Pneumonia Testing Market by Country
6.1.5 North America Immunohistochemistry (IHC) Pneumonia Testing Market by Country
6.1.6 North America Other Technology Pneumonia Testing Market by Country
CHAPTER 7. NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY
7.1 US Pneumonia Testing Market
7.1.1 US Pneumonia Testing Market by Method
7.1.2 US Pneumonia Testing Market by End User
7.1.3 US Pneumonia Testing Market by Type
7.1.4 US Pneumonia Testing Market by Technology
7.2 Canada Pneumonia Testing Market
7.2.1 Canada Pneumonia Testing Market by Method
7.2.2 Canada Pneumonia Testing Market by End User
7.2.3 Canada Pneumonia Testing Market by Type
7.2.4 Canada Pneumonia Testing Market by Technology
7.3 Mexico Pneumonia Testing Market
7.3.1 Mexico Pneumonia Testing Market by Method
7.3.2 Mexico Pneumonia Testing Market by End User
7.3.3 Mexico Pneumonia Testing Market by Type
7.3.4 Mexico Pneumonia Testing Market by Technology
7.4 Rest of North America Pneumonia Testing Market
7.4.1 Rest of North America Pneumonia Testing Market by Method
7.4.2 Rest of North America Pneumonia Testing Market by End User
7.4.3 Rest of North America Pneumonia Testing Market by Type
7.4.4 Rest of North America Pneumonia Testing Market by Technology
CHAPTER 8. COMPANY PROFILES
8.1 ABBOTT Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Revenue & Segment analysis
8.3.4 Research and Development
8.4 Hologic Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Product Wise Revenue:
8.4.5 Research & Development Expense
8.5 Bio-Rad Laboratories, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Thermo Fisher Scientific Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 bioMérieux SA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Meridian Bioscience Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quest Diagnostics Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.1 Quidel Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pneumonia Testing Market, by Method
1.4.2 North America Pneumonia Testing Market, by End User
1.4.3 North America Pneumonia Testing Market, by Type
1.4.4 North America Pneumonia Testing Market, by Technology
1.4.5 North America Pneumonia Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD
3.1.1 North America Point-Of-Care (POC) Testing Pneumonia Testing Market by Country
3.1.2 North America Immunodiagnostics Pneumonia Testing Market by Country
3.1.3 North America Molecular Diagnostics Pneumonia Testing Market by Country
CHAPTER 4. NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER
4.1.1 North America Pneumonia Testing Diagnostic Centers Market by Country
4.1.2 North America Pneumonia Testing Hospitals Market by Country
4.1.3 North America Pneumonia Testing Homecare Market by Country
4.1.4 North America Other End User Pneumonia Testing Market by Country
CHAPTER 5. NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE
5.1.1 North America Analyzers Pneumonia Testing Market by Country
5.1.2 North America Consumables Pneumonia Testing Market by Country
CHAPTER 6. NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY
6.1.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Pneumonia Testing Market by Country
6.1.2 North America Immunofluorescence Pneumonia Testing Market by Country
6.1.3 North America Western Blot Pneumonia Testing Market by Country
6.1.4 North America Polymerase Chain Reaction (PCR) Pneumonia Testing Market by Country
6.1.5 North America Immunohistochemistry (IHC) Pneumonia Testing Market by Country
6.1.6 North America Other Technology Pneumonia Testing Market by Country
CHAPTER 7. NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY
7.1 US Pneumonia Testing Market
7.1.1 US Pneumonia Testing Market by Method
7.1.2 US Pneumonia Testing Market by End User
7.1.3 US Pneumonia Testing Market by Type
7.1.4 US Pneumonia Testing Market by Technology
7.2 Canada Pneumonia Testing Market
7.2.1 Canada Pneumonia Testing Market by Method
7.2.2 Canada Pneumonia Testing Market by End User
7.2.3 Canada Pneumonia Testing Market by Type
7.2.4 Canada Pneumonia Testing Market by Technology
7.3 Mexico Pneumonia Testing Market
7.3.1 Mexico Pneumonia Testing Market by Method
7.3.2 Mexico Pneumonia Testing Market by End User
7.3.3 Mexico Pneumonia Testing Market by Type
7.3.4 Mexico Pneumonia Testing Market by Technology
7.4 Rest of North America Pneumonia Testing Market
7.4.1 Rest of North America Pneumonia Testing Market by Method
7.4.2 Rest of North America Pneumonia Testing Market by End User
7.4.3 Rest of North America Pneumonia Testing Market by Type
7.4.4 Rest of North America Pneumonia Testing Market by Technology
CHAPTER 8. COMPANY PROFILES
8.1 ABBOTT Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Revenue & Segment analysis
8.3.4 Research and Development
8.4 Hologic Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Product Wise Revenue:
8.4.5 Research & Development Expense
8.5 Bio-Rad Laboratories, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Thermo Fisher Scientific Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 bioMérieux SA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Meridian Bioscience Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quest Diagnostics Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.1 Quidel Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 NORTH AMERICA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 2 NORTH AMERICA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 3 NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 4 NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 5 NORTH AMERICA POINT-OF-CARE (POC) TESTING PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 NORTH AMERICA POINT-OF-CARE (POC) TESTING PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 NORTH AMERICA IMMUNODIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 8 NORTH AMERICA IMMUNODIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 9 NORTH AMERICA MOLECULAR DIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 NORTH AMERICA MOLECULAR DIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 12 NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 13 NORTH AMERICA PNEUMONIA TESTING DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 NORTH AMERICA PNEUMONIA TESTING DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 NORTH AMERICA PNEUMONIA TESTING HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 NORTH AMERICA PNEUMONIA TESTING HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 NORTH AMERICA PNEUMONIA TESTING HOMECARE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 NORTH AMERICA PNEUMONIA TESTING HOMECARE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 NORTH AMERICA OTHER END USER PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 NORTH AMERICA OTHER END USER PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 22 NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 23 NORTH AMERICA ANALYZERS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 NORTH AMERICA ANALYZERS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 NORTH AMERICA CONSUMABLES PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 26 NORTH AMERICA CONSUMABLES PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 27 NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 28 NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 29 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 NORTH AMERICA IMMUNOFLUORESCENCE PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 NORTH AMERICA IMMUNOFLUORESCENCE PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 NORTH AMERICA WESTERN BLOT PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 NORTH AMERICA WESTERN BLOT PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 36 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 37 NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 NORTH AMERICA OTHER TECHNOLOGY PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 NORTH AMERICA OTHER TECHNOLOGY PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 US PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 44 US PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 45 US PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 46 US PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 47 US PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 48 US PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 49 US PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 50 US PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 51 US PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 52 US PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 53 CANADA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 54 CANADA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 55 CANADA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 56 CANADA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 57 CANADA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 58 CANADA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 59 CANADA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 60 CANADA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 61 CANADA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 62 CANADA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 63 MEXICO PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 64 MEXICO PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 65 MEXICO PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 66 MEXICO PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 67 MEXICO PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 68 MEXICO PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 69 MEXICO PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 70 MEXICO PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 71 MEXICO PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 72 MEXICO PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 73 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 74 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 75 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 76 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 77 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 78 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 79 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 80 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 81 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 82 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 83 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION- F. HOFFMANN-LA ROCHE LTD.
TABLE 86 KEY INFORMATION – HOLOGIC INC.
TABLE 87 KEY INFORMATION – BIO-RAD LABORATORIES
TABLE 88 KEY INFORMATION – THERMO FISHER SCIENTIFIC INC.
TABLE 89 KEY INFORMATION – BIOMÉRIEUX SA
TABLE 90 KEY INFORMATION – MERIDIAN BIOSCIENCE INC.
TABLE 91 KEY INFORMATION – QUEST DIAGNOSTICS INCORPORATED
TABLE 92 KEY INFORMATION – QUIDEL CORPORATION
TABLE 1 NORTH AMERICA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 2 NORTH AMERICA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 3 NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 4 NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 5 NORTH AMERICA POINT-OF-CARE (POC) TESTING PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 NORTH AMERICA POINT-OF-CARE (POC) TESTING PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 NORTH AMERICA IMMUNODIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 8 NORTH AMERICA IMMUNODIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 9 NORTH AMERICA MOLECULAR DIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 NORTH AMERICA MOLECULAR DIAGNOSTICS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 12 NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 13 NORTH AMERICA PNEUMONIA TESTING DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 NORTH AMERICA PNEUMONIA TESTING DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 NORTH AMERICA PNEUMONIA TESTING HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 NORTH AMERICA PNEUMONIA TESTING HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 NORTH AMERICA PNEUMONIA TESTING HOMECARE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 NORTH AMERICA PNEUMONIA TESTING HOMECARE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 NORTH AMERICA OTHER END USER PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 NORTH AMERICA OTHER END USER PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 22 NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 23 NORTH AMERICA ANALYZERS PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 NORTH AMERICA ANALYZERS PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 NORTH AMERICA CONSUMABLES PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 26 NORTH AMERICA CONSUMABLES PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 27 NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 28 NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 29 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 NORTH AMERICA IMMUNOFLUORESCENCE PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 NORTH AMERICA IMMUNOFLUORESCENCE PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 NORTH AMERICA WESTERN BLOT PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 NORTH AMERICA WESTERN BLOT PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 36 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 37 NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 NORTH AMERICA OTHER TECHNOLOGY PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 NORTH AMERICA OTHER TECHNOLOGY PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 NORTH AMERICA PNEUMONIA TESTING MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 US PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 44 US PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 45 US PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 46 US PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 47 US PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 48 US PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 49 US PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 50 US PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 51 US PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 52 US PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 53 CANADA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 54 CANADA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 55 CANADA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 56 CANADA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 57 CANADA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 58 CANADA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 59 CANADA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 60 CANADA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 61 CANADA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 62 CANADA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 63 MEXICO PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 64 MEXICO PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 65 MEXICO PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 66 MEXICO PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 67 MEXICO PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 68 MEXICO PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 69 MEXICO PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 70 MEXICO PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 71 MEXICO PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 72 MEXICO PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 73 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET, 2014 - 2017, USD MILLION
TABLE 74 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET, 2018 - 2024, USD MILLION
TABLE 75 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2014 - 2017, USD MILLION
TABLE 76 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY METHOD, 2018 - 2024, USD MILLION
TABLE 77 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 78 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 79 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 80 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 81 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 82 REST OF NORTH AMERICA PNEUMONIA TESTING MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 83 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION- F. HOFFMANN-LA ROCHE LTD.
TABLE 86 KEY INFORMATION – HOLOGIC INC.
TABLE 87 KEY INFORMATION – BIO-RAD LABORATORIES
TABLE 88 KEY INFORMATION – THERMO FISHER SCIENTIFIC INC.
TABLE 89 KEY INFORMATION – BIOMÉRIEUX SA
TABLE 90 KEY INFORMATION – MERIDIAN BIOSCIENCE INC.
TABLE 91 KEY INFORMATION – QUEST DIAGNOSTICS INCORPORATED
TABLE 92 KEY INFORMATION – QUIDEL CORPORATION
